Answers are grounded in this paper and cite their sources.
Observational analysis reveals that microvesicles from activated T cells enhance mast cell migration through S1P1 receptor signaling, emphasizing their role in T cell-mediated inflammation.
Morphologic studies show increased mast cell activation during T cell-mediated inflammation. Previous research demonstrated that microvesicles from activated T cells (MVT*), but not resting T cells (MVT), stimulate human mast cells via the MAPK pathway, leading to degranulation and cytokine release. This study investigates whether MVT* also promote mast cell migration. MVT and MVT* were isolated from T cell supernatants and mast cell migration was measured using a transwell assay. The molecular mechanisms were analyzed with specific inhibitors. Results showed that MVT* significantly enhanced human mast cells chemotaxis, which dependent on ERK and p38 phosphorylation but not on PI3K. In addition, migration was mediated by the S1P1 receptor rather than S1P2 and by sphingosine kinases 1, indicating a role for S1P1 in MVT*-induced mast cell migration. In summary, MVT* act as chemoattractants, guiding mast cells to inflammatory sites where they become activated, highlighting their importance in T cell-mediated inflammation.
No takes yet. Share an insight, caveat, or question.
Yishay et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: